These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8092829)

  • 1. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
    Berenguer J; Ali NM; Allende MC; Lee J; Garrett K; Battaglia S; Piscitelli SC; Rinaldi MG; Pizzo PA; Walsh TJ
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1303-8. PubMed ID: 8092829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
    Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Prince RA; Chi J; Kontoyiannis DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
    Patterson TF; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
    Denning DW; Hall L; Jackson M; Hollis S
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.
    Allende MC; Lee JW; Francis P; Garrett K; Dollenberg H; Berenguer J; Lyman CA; Pizzo PA; Walsh TJ
    Antimicrob Agents Chemother; 1994 Mar; 38(3):518-22. PubMed ID: 8203848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
    Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
    Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
    Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
    Petraitis V; Petraitiene R; Solomon J; Kelaher AM; Murray HA; Mya-San C; Bhandary AK; Sein T; Avila NA; Basevicius A; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1510-7. PubMed ID: 16569871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
    Petraitis V; Petraitiene R; Groll AH; Bell A; Callender DP; Sein T; Schaufele RL; McMillian CL; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2898-905. PubMed ID: 9797223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis.
    Dannaoui E; Borel E; Persat F; Piens MA; Picot S
    J Med Microbiol; 2000 Jul; 49(7):601-606. PubMed ID: 10882084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
    Caillot D
    Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism.
    Schaffner A; Böhler A
    Mycoses; 1993; 36(11-12):421-4. PubMed ID: 7935575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
    Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
    Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
    Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
    J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.
    Wiederhold NP; Tam VH; Chi J; Prince RA; Kontoyiannis DP; Lewis RE
    Antimicrob Agents Chemother; 2006 Feb; 50(2):469-73. PubMed ID: 16436698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole--perspectives for the management of invasive aspergillosis.
    Groll AH
    Mycoses; 2002; 45 Suppl 3():48-55. PubMed ID: 12690972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
    Dannaoui E; Meletiadis J; Tortorano AM; Symoens F; Nolard N; Viviani MA; Piens MA; Lebeau B; Verweij PE; Grillot R; And The Ebga Network
    J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.